| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 31-Dec-08 | | Total Revenue | 112,838 | 109,086 | 100,395 | 106,125 | | Cost of Revenue | 28,608 | 30,478 | 30,988 | 34,809 | | | Gross Profit | 84,230 | 78,608 | 69,407 | 71,316 | | | Operating Expenses | | Research Development | 12,545 | 12,310 | 11,578 | 10,871 | | Selling General and Administrative | 57,497 | 54,961 | 55,648 | 53,188 | | Non Recurring | (196) | 196 |
-
| 288,931 | | Others | 6,802 | 5,814 | 5,828 | 6,787 | | | | Total Operating Expenses | 76,648 | 73,281 |
-
| 359,777 | | | | Operating Income or Loss | 7,582 | 5,327 | (3,647) | (288,461) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 143 | 716 | 1,859 | (1,228) | | Earnings Before Interest And Taxes | 7,150 | 6,043 | (1,788) | (289,689) | | Interest Expense | (435) | 222 | 213 | 1,146 | | Income Before Tax | 7,585 | 5,821 | (2,001) | (290,835) | | Income Tax Expense | 849 | (18,168) | (192) | 285 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,736 | 23,989 | (1,809) | (291,120) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,736 | 23,989 | (1,809) | (291,120) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,736 | $23,989 | ($1,809) | ($291,120) |
|
0.51% Nasdaq 
0.04 (0.29%) 
Income Statement
